The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans
- 1 August 1999
- journal article
- research article
- Published by Wiley
- Vol. 48 (2) , 180-189
- https://doi.org/10.1046/j.1365-2125.1999.00999.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Enantiomeric separation of verapamil and norverapamil using Chiral-AGP® as the stationary phaseJournal of Pharmaceutical and Biomedical Analysis, 1999
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.Journal of Clinical Investigation, 1997
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProceedings of the National Academy of Sciences, 1997
- Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by RifampinHepatology, 1996
- Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug deliveryJournal of Controlled Release, 1996
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- Simultaneous analysis of verapamil and norverapamil enantiomers in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.Journal of Clinical Investigation, 1987
- Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences, 1987